{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:42:10Z","timestamp":1762324930266,"version":"3.44.0"},"reference-count":255,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780128203552"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.irn.2020.09.002","type":"book-chapter","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T18:48:28Z","timestamp":1612291708000},"page":"31-68","source":"Crossref","is-referenced-by-count":8,"title":["Pain, negative affective states and opioid-based analgesics: Safer pain therapies to dampen addiction"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.irn.2020.09.002_bb0010","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0022-3565(25)20227-0","article-title":"Selective blockage of delta opioid receptor prevents the development of morphine tolerance and dependence in mice","volume":"258","author":"Abdelhamid","year":"1991","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2020.09.002_bb0015","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neuron.2015.08.019","article-title":"Distinct subpopulations of nucleus accumbens dynorphin neurons drive aversion and reward","volume":"87","author":"Al-Hasani","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/bs.irn.2020.09.002_bb0020","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/FBP.0b013e32834aff54","article-title":"Some determinants of morphine effects on intracranial self-stimulation in rats: Dose, pretreatment time, repeated treatment, and rate dependence","volume":"22","author":"Altarifi","year":"2011","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1523\/JNEUROSCI.15-01-00165.1995","article-title":"Perineurial defect and peripheral opioid analgesia in inflammation","volume":"15","author":"Antonijevic","year":"1995","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0030","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/WCO.0b013e32836336ad","article-title":"Predicting transition to chronic pain","volume":"26","author":"Apkarian","year":"2013","journal-title":"Current Opinion in Neurology"},{"key":"10.1016\/bs.irn.2020.09.002_bb9010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pain.2003.12.015","article-title":"Chronic pain patients are impaired on an emotional decision making task","volume":"108","author":"Apkarian","year":"2004","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0035","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1523\/JNEUROSCI.15-02-01215.1995","article-title":"Delta-opioid receptor immunoreactivity: Distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin","volume":"15","author":"Arvidsson","year":"1995","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0040","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1523\/JNEUROSCI.15-05-03328.1995","article-title":"Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord","volume":"15","author":"Arvidsson","year":"1995","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2012.07.018","article-title":"Effects of peripheral \u03ba opioid receptor activation on inflammatory mechanical hyperalgesia in male and female rats","volume":"524","author":"Auh","year":"2012","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.irn.2020.09.002_bb0050","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.neuron.2015.06.005","article-title":"Nociception, pain, negative moods, and behavior selection","volume":"87","author":"Baliki","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/bs.irn.2020.09.002_bb9015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuron.2010.03.002","article-title":"Predicting value of pain and analgesia: Nucleus accumbens response to noxious stimuli changes in the presence of chronic pain","volume":"66","author":"Baliki","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/bs.irn.2020.09.002_bb0055","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1476-5381.1994.tb17142.x","article-title":"A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753","volume":"113","author":"Barber","year":"1994","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0060","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"10.1016\/bs.irn.2020.09.002_bb0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.ne.07.030184.001521","article-title":"Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry","volume":"7","author":"Basbaum","year":"1984","journal-title":"Annual Review of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0070","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/ejn.12829","article-title":"Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain","volume":"41","author":"Beaudry","year":"2015","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0075","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ejpain.2007.12.007","article-title":"Signal valence in the nucleus accumbens to pain onset and offset","volume":"12","author":"Becerra","year":"2008","journal-title":"European Journal of Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0080","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1152\/jn.00284.2013","article-title":"Analogous responses in the nucleus accumbens and cingulate cortex to pain onset (aversion) and offset (relief) in rats and humans","volume":"110","author":"Becerra","year":"2013","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0085","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)01313-6","article-title":"The neurobiology of pain","volume":"353","author":"Besson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/bs.irn.2020.09.002_bb0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuroscience.2008.08.045","article-title":"Decreased motivational properties of morphine in mouse models of cancerous- or inflammatory-chronic pain: Implication of supraspinal neuropeptide FF2 receptors","volume":"157","author":"Betourne","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0095","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1460-9568.2010.07314.x","article-title":"Disruption of morphine conditioned place preference by delta-2-opioid receptor antagonist: Study of mu- and delta-opioid receptor expression at the synapse","volume":"32","author":"Billa","year":"2010","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0100","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/00000542-200106000-00018","article-title":"Analgesic and antiinflammatory effects of two novel kappa-opioid peptides","volume":"94","author":"Binder","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0105","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/sj.bjp.0701874","article-title":"Effect of the peripherally selective \u03ba-opioid agonist, asimadoline, on adjuvant arthritis","volume":"124","author":"Binder","year":"1998","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0110","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pain.2009.09.008","article-title":"Drug dependent sex differences in periaqueducatal gray mediated antinociception in the rat","volume":"147","author":"Bobeck","year":"2009","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0115","doi-asserted-by":"crossref","first-page":"170223","DOI":"10.1016\/j.peptides.2019.170223","article-title":"Endogenous opiates and behavior: 2017","volume":"124","author":"Bodnar","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/bs.irn.2020.09.002_bb0120","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jpain.2016.03.002","article-title":"Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain","volume":"17","author":"Boehnke","year":"2016","journal-title":"The Journal of Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0125","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking beta-arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"key":"10.1016\/bs.irn.2020.09.002_bb0130","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1152\/jn.00249.2003","article-title":"fMRI measurement of CNS responses to naloxone infusion and subsequent mild noxious thermal stimuli in healthy volunteers","volume":"91","author":"Borras","year":"2004","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0135","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuroscience.2017.08.044","article-title":"A quantitative study of neurochemically defined populations of inhibitory interneurons in the superficial dorsal horn of the mouse spinal cord","volume":"363","author":"Boyle","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb9020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0022-3565(24)29271-5","article-title":"Studies of tolerance and dependence with the delta-opioid agonist SNC80 in rhesus monkeys responding under a schedule of food presentation","volume":"299","author":"Brandt","year":"2001","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2020.09.002_bb9025","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0893-133X(01)00413-4","article-title":"Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats","volume":"26","author":"Broom","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb9030","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1124\/jpet.102.036525","article-title":"Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice","volume":"303","author":"Broom","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2020.09.002_bb0140","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/ALN.0000000000002840","article-title":"Combination of a \u03b4-opioid receptor agonist and loperamide produces peripherally-mediated analgesic synergy in mice","volume":"131","author":"Bruce","year":"2019","journal-title":"Anesthesiology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00213-010-1806-y","article-title":"Kinase cascades and ligand-directed signaling at the kappa opioid receptor","volume":"210","author":"Bruchas","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2009.08.062","article-title":"The dynorphin\/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors","volume":"1314","author":"Bruchas","year":"2010","journal-title":"Brain Research"},{"key":"10.1016\/bs.irn.2020.09.002_bb0155","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1213\/01.ANE.0000152191.29311.9B","article-title":"Age-dependent opioid escalation in chronic pain patients","volume":"100","author":"Buntin-Mushock","year":"2005","journal-title":"Anesthesia and Analgesia"},{"key":"10.1016\/bs.irn.2020.09.002_bb0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tips.2006.11.003","article-title":"Trafficking of delta-opioid receptors and other G-protein-coupled receptors: Implications for pain and analgesia","volume":"28","author":"Cahill","year":"2007","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/bs.irn.2020.09.002_bb0165","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0304-3959(02)00333-0","article-title":"Up-regulation and trafficking of delta opioid receptor in a model of chronic inflammation: Implications for pain control","volume":"101","author":"Cahill","year":"2003","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0170","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/164_2018_112","article-title":"Evidence and function relevance of native DOR-MOR heteromers","volume":"247","author":"Cahill","year":"2018","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0175","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fphar.2014.00253","article-title":"Does the kappa opioid receptor system contribute to pain aversion?","volume":"5","author":"Cahill","year":"2014","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0180","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/FBP.0b013e3283618ac8","article-title":"Changes in morphine reward in a model of neuropathic pain","volume":"24","author":"Cahill","year":"2013","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2007.06.034","article-title":"Subcutaneous, intrathecal and periaqueductal grey administration of asimadoline and ICI-204448 reduces tactile allodynia in the rat","volume":"573","author":"Caram-Salas","year":"2007","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0190","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1523\/JNEUROSCI.3536-06.2007","article-title":"Activation of the extracellular signal-regulated kinase in the amygdala modulates pain perception","volume":"27","author":"Carrasquillo","year":"2007","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0195","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1523\/JNEUROSCI.4458-13.2014","article-title":"Opioid hedonic hotspot in nucleus accumbens shell: Mu, delta, and kappa maps for enhancement of sweetness \u201cliking\u201d and \u201cwanting\u201d","volume":"34","author":"Castro","year":"2014","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0200","first-page":"299","article-title":"Intraoperative low-dose ketamine infusion reduces acute postoperative pain following total knee replacement surgery: A prospective, randomized double-blind placebo-controlled trial","volume":"24","author":"Cengiz","year":"2014","journal-title":"Journal of the College of Physicians and Surgeons\u2013Pakistan"},{"key":"10.1016\/bs.irn.2020.09.002_bb0205","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/npp.2010.137","article-title":"The therapeutic potential of \u03ba-opioids for treatment of pain and addiction","volume":"36","author":"Chavkin","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0210","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.6120570","article-title":"Dynorphin is a specific endogenous ligand of the kappa opioid receptor","volume":"215","author":"Chavkin","year":"1982","journal-title":"Science"},{"key":"10.1016\/bs.irn.2020.09.002_bb0215","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/npp.2015.258","article-title":"Dynorphin, dysphoria, and dependence: The stress of addiction","volume":"41","author":"Chavkin","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0220","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/j.1532-2149.2012.00148.x","article-title":"Analgesic properties of loperamide differ following systemic and local administration to rats after spinal nerve injury","volume":"16","author":"Chung","year":"2012","journal-title":"European Journal of Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb9035","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.biopsych.2014.07.033","article-title":"A novel anxiogenic role for the delta opioid receptor expressed in GABAergic forebrain neurons","volume":"77","author":"Chung","year":"2015","journal-title":"Biological Psychiatry"},{"key":"10.1016\/bs.irn.2020.09.002_bb0225","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.lfs.2003.09.038","article-title":"Synergistic interactions between cannabinoid and opioid analgesics","volume":"74","author":"Cichewicz","year":"2004","journal-title":"Life Sciences"},{"key":"10.1016\/bs.irn.2020.09.002_bb0230","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.japh.2016.02.012","article-title":"Prescription opioid use: Patient characteristics and misuse in community pharmacy","volume":"56","author":"Cochran","year":"2016","journal-title":"Journal of the American Pharmaceutical Association"},{"key":"10.1016\/bs.irn.2020.09.002_bb0235","doi-asserted-by":"crossref","first-page":"8538","DOI":"10.1073\/pnas.1430684100","article-title":"Neural correlates of interindividual differences in the subjective experience of pain","volume":"100","author":"Coghill","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.irn.2020.09.002_bb0240","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0024-3205(82)90402-7","article-title":"Further evidence validating adjuvant arthritis as an experimental model of chronic pain in the rat","volume":"31","author":"Colpaert","year":"1982","journal-title":"Life Sciences"},{"key":"10.1016\/bs.irn.2020.09.002_bb0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3959(00)00413-9","article-title":"Opiate self-administration as a measure of chronic nociceptive pain in arthritic rats","volume":"91","author":"Colpaert","year":"2001","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb9040","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0022-3565(25)39544-3","article-title":"Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice","volume":"267","author":"Comer","year":"1993","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2020.09.002_bb0250","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1126\/science.aap8586","article-title":"An amygdalar neural ensemble that encodes the unpleasantness of pain","volume":"363","author":"Corder","year":"2019","journal-title":"Science"},{"key":"10.1016\/bs.irn.2020.09.002_bb0255","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nm.4262","article-title":"Loss of \u03bc opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia","volume":"23","author":"Corder","year":"2017","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.irn.2020.09.002_bb0260","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.39945","article-title":"Dopamine neurons projecting to medial shell of the nucleus accumbens drive heroin reinforcement","volume":"7","author":"Corre","year":"2018","journal-title":"eLife"},{"key":"10.1016\/bs.irn.2020.09.002_bb0265","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-3-662-44605-8_16","article-title":"Targeting itch with ligands selective for \u03ba opioid receptors","volume":"226","author":"Cowan","year":"2015","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0270","doi-asserted-by":"crossref","first-page":"14217","DOI":"10.1523\/JNEUROSCI.1473-12.2012","article-title":"Central amygdala metabotropic glutamate receptor 5 in the modulation of visceral pain","volume":"32","author":"Crock","year":"2012","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0275","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1016\/j.celrep.2016.02.069","article-title":"Dynorphin controls the gain of an amygdalar anxiety circuit","volume":"14","author":"Crowley","year":"2016","journal-title":"Cell Reports"},{"key":"10.1016\/bs.irn.2020.09.002_bb0280","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nn.3622","article-title":"Targeted expression of \u03bc-opioid receptors in a subset of striatal direct-pathway neurons restores opiate reward","volume":"17","author":"Cui","year":"2014","journal-title":"Nature Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0285","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1744-8069-8-10","article-title":"Stimulation of peripheral kappa opioid receptors inhibits inflammatory hyperalgesia via activation of the PI3K\u03b3\/AKT\/nNOS\/NO signaling pathway","volume":"8","author":"Cunha","year":"2012","journal-title":"Molecular Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0290","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/ALN.0000000000000402","article-title":"Comorbidities and the complexities of chronic pain","volume":"121","author":"Dahan","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/bs.irn.2020.09.002_bb9045","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.pbb.2006.09.012","article-title":"Electroencephalographic and convulsant effects of the delta opioid agonist SNC80 in rhesus monkeys","volume":"85","author":"Danielsson","year":"2006","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/bs.irn.2020.09.002_bb0295","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1016\/S0024-3205(02)02102-1","article-title":"Antipruritic and antihyperalgesic actions of loperamide and analogs","volume":"71","author":"DeHaven-Hudkins","year":"2002","journal-title":"Life Sciences"},{"key":"10.1016\/bs.irn.2020.09.002_bb0300","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/1381612043453036","article-title":"Peripherally restricted opioid agonists as novel analgesic agents","volume":"10","author":"DeHaven-Hudkins","year":"2004","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/bs.irn.2020.09.002_bb0305","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nn.3628","article-title":"Pain vulnerability: A neurobiological perspective","volume":"17","author":"Denk","year":"2014","journal-title":"Nature Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0310","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010107.pub2","article-title":"Single dose oral ibuprofen plus paracetamol (acetaminophen) for acute postoperative pain","volume":"2013","author":"Derry","year":"2013","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/bs.irn.2020.09.002_bb0315","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0022-3565(25)39324-9","article-title":"Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: In vivo microdialysis studies","volume":"266","author":"Devine","year":"1993","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2020.09.002_bb0320","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/bs.irn.2020.09.002_bb9050","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0022-3565(25)39537-6","article-title":"A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration","volume":"267","author":"Dykstra","year":"1993","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2020.09.002_bb0325","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00000539-200107000-00042","article-title":"The reversal of fentanyl-induced tolerance by administration of \u201csmall-dose\u201d ketamine","volume":"93","author":"Eilers","year":"2001","journal-title":"Anesthesia and Analgesia"},{"key":"10.1016\/bs.irn.2020.09.002_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.06.003","article-title":"Pain and suicidality: Insights from reward and addiction neuroscience","volume":"109","author":"Elman","year":"2013","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0335","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/ejp.687","article-title":"Reward responsiveness in patients with chronic pain","volume":"19","author":"Elvemo","year":"2015","journal-title":"European Journal of Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0340","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/ALN.0b013e3182330448","article-title":"Rewarding electrical brain stimulation in rats after peripheral nerve injury: Decreased facilitation by commonly abused prescription opioids","volume":"115","author":"Ewan","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0345","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/ALN.0b013e3182518be3","article-title":"Intracranial self-stimulation of the paraventricular nucleus of the hypothalamus: Increased faciliation by morphine compared to cocaine","volume":"116","author":"Ewan","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0350","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1213\/ANE.0000000000000119","article-title":"Differential suppression of intracranial self-stimulation, food-maintained operant responding, and open field activity by paw incision and spinal nerve ligation in rats","volume":"118","author":"Ewan","year":"2014","journal-title":"Anesthesia and Analgesia"},{"key":"10.1016\/bs.irn.2020.09.002_bb0355","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0006-8993(89)91033-0","article-title":"Opioid peptides (DAGO-enkephalin, dynorphin A(1-13), BAM 22P) microinjected into the rat brainstem: Comparison of their antinociceptive effect and their effect on neuronal firing in the rostral ventromedial medulla","volume":"501","author":"Fang","year":"1989","journal-title":"Brain Research"},{"key":"10.1016\/bs.irn.2020.09.002_bb0360","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tins.2015.01.002","article-title":"Understanding opioid reward","volume":"38","author":"Fields","year":"2015","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/bs.irn.2020.09.002_bb0365","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0022-3565(24)39015-9","article-title":"Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat","volume":"295","author":"Fraser","year":"2000","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2020.09.002_bb0370","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1111\/bph.12798","article-title":"Revolution in GPCR signalling: Opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10","volume":"171","author":"Fujita","year":"2014","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0375","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/bph.12663","article-title":"Heteromers of \u03bc-\u03b4 opioid receptors: New pharmacology and novel therapeutic possibilities","volume":"172","author":"Fujita","year":"2015","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0380","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1155\/2011\/465281","article-title":"A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer pain","volume":"16","author":"Furlan","year":"2011","journal-title":"Pain Research & Management"},{"key":"10.1016\/bs.irn.2020.09.002_bb9055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1742-7843.2005.pto_97107.x","article-title":"A comparison of the antinociceptive and adverse effects of the mu-opioid agonist morphine and the delta-opioid agonist SNC80","volume":"97","author":"Gallantine","year":"2005","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0385","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.pop.2012.06.013","article-title":"Pain processing in the human nervous system: A selective review of nociceptive and biobehavioral pathways","volume":"39","author":"Garland","year":"2012","journal-title":"Primary Care"},{"key":"10.1016\/bs.irn.2020.09.002_bb0390","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.neubiorev.2013.08.006","article-title":"The downward spiral of chronic pain, prescription opioid misuse, and addiction: Cognitive, affective, and neuropsychopharmacologic pathways","volume":"37","author":"Garland","year":"2013","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/bs.irn.2020.09.002_bb0395","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1111\/j.1460-9568.2008.06223.x","article-title":"Inflammatory pain is enhanced in delta opioid receptor-knockout mice","volume":"27","author":"Gav\u00e9riaux-Ruff","year":"2008","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0400","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/FBP.0b013e32834a1f2c","article-title":"Delta opioid receptor analgesia: Recent contributions from pharmacology and molecular approaches","volume":"22","author":"Gav\u00e9riaux-Ruff","year":"2011","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0405","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1523\/JNEUROSCI.3598-05.2006","article-title":"Morphine and pain-related stimuli enhance cell surface availability of somatic \u03b4-opioid receptors in rat dorsal root ganglia","volume":"26","author":"Gendron","year":"2006","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0410","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/bph.12706","article-title":"Recent advances on the \u03b4 opioid receptor: From trafficking to function","volume":"172","author":"Gendron","year":"2015","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0415","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00213-012-2949-9","article-title":"Attenuation of cocaine and heroin seeking by \u03bc-opioid receptor antagonism","volume":"227","author":"Giuliano","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0420","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00002508-200009000-00002","article-title":"Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia","volume":"16","author":"Graff-Radford","year":"2000","journal-title":"The Clinical Journal of Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0425","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41386-019-0491-8","article-title":"A G protein signaling-biased agonist at the \u03bc-opioid receptor reverses morphine tolerance while preventing morphine withdrawal","volume":"45","author":"Grim","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0430","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.pain.2008.01.004","article-title":"Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury","volume":"138","author":"Guan","year":"2008","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0435","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1021\/acs.jmedchem.8b01679","article-title":"Design and synthesis of a novel and selective kappa opioid receptor (KOR) antagonist (BTRX-335140)","volume":"62","author":"Guerrero","year":"2019","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.irn.2020.09.002_bb0440","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1111\/bph.13809","article-title":"Targeting multiple opioid receptors\u2014Improved analgesics with reduced side effects?","volume":"175","author":"G\u00fcnther","year":"2018","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0445","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1073\/pnas.1521825113","article-title":"Collybolide is a novel biased agonist of \u03ba-opioid receptors with potent antipruritic activity","volume":"113","author":"Gupta","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.irn.2020.09.002_bb0450","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cell.2015.05.057","article-title":"Elucidating an affective pain circuit that creates a threat memory","volume":"162","author":"Han","year":"2015","journal-title":"Cell"},{"key":"10.1016\/bs.irn.2020.09.002_bb0455","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/ALN.0000000000000963","article-title":"Differential opioid tolerance and opioid-induced hyperalgesia: A clinical reality","volume":"124","author":"Hayhurst","year":"2016","journal-title":"Anesthesiology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0460","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.brainresrev.2008.12.009","article-title":"Descending control of nociception: Specificity, recruitment and plasticity","volume":"60","author":"Heinricher","year":"2009","journal-title":"Brain Research Reviews"},{"key":"10.1016\/bs.irn.2020.09.002_bb0465","doi-asserted-by":"crossref","first-page":"12217","DOI":"10.1523\/JNEUROSCI.1053-15.2015","article-title":"Inflammatory pain promotes increased opioid self-administration: Role of dysregulated ventral tegmental area \u03bc opioid receptors","volume":"35","author":"Hip\u00f3lito","year":"2015","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0470","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nature04172","article-title":"Morphine reward in dopamine-deficient mice","volume":"438","author":"Hnasko","year":"2005","journal-title":"Nature"},{"key":"10.1016\/bs.irn.2020.09.002_bb0475","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(24)36556-5","article-title":"Putative kappa-2 opioid agonists are antihyperalgesic in a rat model of inflammation","volume":"281","author":"Ho","year":"1997","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2020.09.002_bb0480","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41386-020-0600-8","article-title":"Addiction is driven by excessive goal-directed drug choice under negative affect: Translational critique of habit and compulsion theory","volume":"45","author":"Hogarth","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0485","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1523\/JNEUROSCI.3453-14.2015","article-title":"Persistent pain maintains morphine-seeking behavior after morphine withdrawal through reduced MeCP2 repression of Glua1 in rat central amygdala","volume":"35","author":"Hou","year":"2015","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0490","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1523\/JNEUROSCI.20-03-01249.2000","article-title":"The analgesic effects of supraspinal \u03bc and \u03b4 opioid receptor agonists are potentiated during persistent inflammation","volume":"20","author":"Hurley","year":"2000","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0495","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejphar.2004.09.010","article-title":"Kappa opioid agonists suppress chloroquine-induced scratching in mice","volume":"502","author":"Inan","year":"2004","journal-title":"European Journal of Pharmacology"},{"year":"2011","series-title":"Relieving pain in America: A blueprint for transforming prevention, care, education, and research","author":"Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education","key":"10.1016\/bs.irn.2020.09.002_bb0500"},{"key":"10.1016\/bs.irn.2020.09.002_bb0505","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1126\/science.185.4156.1055","article-title":"Paradoxical effects after microinjection of morphine in the periaqueductal gray matter in the rat","volume":"185","author":"Jacquet","year":"1974","journal-title":"Science"},{"key":"10.1016\/bs.irn.2020.09.002_bb0510","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/13854046.2012.715204","article-title":"Risk factor assessment for problematic use of opioids for chronic pain","volume":"27","author":"Jamison","year":"2013","journal-title":"The Clinical Neuropsychologist"},{"key":"10.1016\/bs.irn.2020.09.002_bb0515","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nature14188","article-title":"From circuits to behaviour in the amygdala","volume":"517","author":"Janak","year":"2015","journal-title":"Nature"},{"key":"10.1016\/bs.irn.2020.09.002_bb0520","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.aaf8924","article-title":"Pain regulation by non-neuronal cells and inflammation","volume":"354","author":"Ji","year":"2016","journal-title":"Science"},{"key":"10.1016\/bs.irn.2020.09.002_bb9060","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","article-title":"Opioids excite dopamine neurons by hyperpolarization of local interneurons","volume":"12","author":"Johnson","year":"1992","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0525","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/adb.12163","article-title":"Abuse potential of intranasal buprenorphine versus buprenorphine\/naloxone in buprenorphine-maintained heroin users","volume":"20","author":"Jones","year":"2015","journal-title":"Addiction Biology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0530","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/35093019","article-title":"Molecular mechanisms of nociception","volume":"413","author":"Julius","year":"2001","journal-title":"Nature"},{"key":"10.1016\/bs.irn.2020.09.002_bb9065","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1124\/jpet.105.095810","article-title":"The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: Comparison with pentylenetetrazol","volume":"317","author":"Jutkiewicz","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2020.09.002_bb0535","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0014-2999(95)00122-2","article-title":"Antinociceptive effect of a kappa-opioid receptor agonist that minimally crosses the blood-brain barrier (ICI 204448) in a rat model of mononeuropathy","volume":"277","author":"Ke\u00efta","year":"1995","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0540","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/nn.2407","article-title":"Unmasking the tonic-aversive state in neuropathic pain","volume":"12","author":"King","year":"2009","journal-title":"Nature Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0545","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/nrd4784","article-title":"Pioneering biased ligand offers efficacy with reduced on-target toxicity","volume":"14","author":"Kingwell","year":"2015","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/bs.irn.2020.09.002_bb0550","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00213-010-1819-6","article-title":"Kappa opioids and the modulation of pain","volume":"210","author":"Kivell","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb9070","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41467-018-08162-1","article-title":"Phosphorylation-deficient G-protein-biased \u03bc-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects","volume":"10","author":"Kliewer","year":"2019","journal-title":"Nature Communications"},{"key":"10.1016\/bs.irn.2020.09.002_bb0555","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1111\/bph.15004","article-title":"Morphine-induced respiratory depression is independent of \u03b2-arrestin2 signalling","volume":"177","author":"Kliewer","year":"2020","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0560","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/msc.1076","article-title":"Multidisciplinary rehabilitation for chronic widespread musculoskeletal pain: Results from daily practice","volume":"12","author":"Koele","year":"2014","journal-title":"Musculoskeletal Care"},{"key":"10.1016\/bs.irn.2020.09.002_bb0565","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","article-title":"Drug addiction, dysregulation of reward, and allostasis","volume":"24","author":"Koob","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0570","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0575","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: A neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/bs.irn.2020.09.002_bb0580","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11916-016-0596-2","article-title":"Challenges to treatment of chronic pain and addiction during the \u201copioid crisis\u201d","volume":"20","author":"Krashin","year":"2016","journal-title":"Current Pain and Headache Reports"},{"key":"10.1016\/bs.irn.2020.09.002_bb0585","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3959(94)00106-O","article-title":"The consumption of fentanyl is increased in rats with nociceptive but not with neuropathic pain","volume":"60","author":"Kupers","year":"1995","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0590","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2005.05.008","article-title":"Selective regulation of pain affect following activation of the opioid anterior cingulate cortex system","volume":"197","author":"LaGraize","year":"2006","journal-title":"Experimental Neurology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0595","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neulet.2008.03.088","article-title":"Pronociceptive actions of dynorphin via bradykinin receptors","volume":"437","author":"Lai","year":"2008","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.irn.2020.09.002_bb0600","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fpsyt.2014.00170","article-title":"The kappa opioid receptor: From addiction to depression, and back","volume":"5","author":"Lalanne","year":"2014","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/bs.irn.2020.09.002_bb0605","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","article-title":"The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system","volume":"28","author":"Land","year":"2008","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0610","doi-asserted-by":"crossref","first-page":"19168","DOI":"10.1073\/pnas.0910705106","article-title":"Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking","volume":"106","author":"Land","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.irn.2020.09.002_bb0615","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuroscience.2005.06.014","article-title":"Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats","volume":"135","author":"Lane","year":"2005","journal-title":"Neuroscience"},{"issue":"68\u201370","key":"10.1016\/bs.irn.2020.09.002_bb0620","first-page":"62","article-title":"Pain management: The fifth vital sign","volume":"8","author":"Lanser","year":"2001","journal-title":"Healthcare Benchmarks"},{"key":"10.1016\/bs.irn.2020.09.002_bb0625","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nn1182","article-title":"Opiate state controls bi-directional reward signaling via GABAA receptors in the ventral tegmental area","volume":"7","author":"Laviolette","year":"2004","journal-title":"Nature Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb9075","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","article-title":"Reward processing by the opioid system in the brain","volume":"89","author":"Le Merrer","year":"2009","journal-title":"Physiological Reviews"},{"key":"10.1016\/bs.irn.2020.09.002_bb0630","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.117.246215","article-title":"Repeated morphine produces sensitization to reward and tolerance to anti-allodynia in male and female rats with chemotherapy-induced neuropathy","volume":"365","author":"Legakis","year":"2018","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2020.09.002_bb0635","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/npp.2013.236","article-title":"Pain-related depression of the mesolimbic dopamine system in rats: Expression, blockade by analgesics, and role of endogenous \u03ba-opioids","volume":"39","author":"Leitl","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0640","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1744-8069-10-62","article-title":"Sustained pain-related depression of behavior: Effects of intraplantar formalin and complete freund's adjuvant on intracranial self-stimulation (ICSS) and endogenous kappa opioid biomarkers in rats","volume":"10","author":"Leitl","year":"2014","journal-title":"Molecular Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0645","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nrn2333","article-title":"A common neurobiology for pain and pleasure","volume":"9","author":"Leknes","year":"2008","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb9080","doi-asserted-by":"crossref","first-page":"11172","DOI":"10.1523\/JNEUROSCI.1781-11.2011","article-title":"Identification of a dopamine receptor-mediated opiate reward memory switch in the basolateral amygdala-nucleus accumbens circuit","volume":"31","author":"Lintas","year":"2011","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb9085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1460-9568.2011.07943.x","article-title":"Inputs from the basolateral amygdala to the nucleus accumbens shell control opiate reward magnitude via differential dopamine D1 or D2 receptor transmission","volume":"35","author":"Lintas","year":"2012","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0650","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1523\/JNEUROSCI.0274-19.2019","article-title":"Kappa opioid receptors drive a tonic aversive component of chronic pain","volume":"39","author":"Liu","year":"2019","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0655","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/ALN.0b013e3181e90914","article-title":"Intraoperative ketamine reduces perioperative opiate consumption in opiate-dependent patients with chronic back pain undergoing back surgery","volume":"113","author":"Loftus","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0660","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","volume":"4","author":"Lunn","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/bs.irn.2020.09.002_bb0665","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/0024-3205(89)90062-3","article-title":"Morphine self-administration in the rat during adjuvant-induced arthritis","volume":"45","author":"Lyness","year":"1989","journal-title":"Life Sciences"},{"key":"10.1016\/bs.irn.2020.09.002_bb0670","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"key":"10.1016\/bs.irn.2020.09.002_bb0675","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0166-2236(88)90093-8","article-title":"Anatomy of CNS opioid receptors","volume":"11","author":"Mansour","year":"1988","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/bs.irn.2020.09.002_bb0680","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jpain.2013.09.014","article-title":"The association between negative affect and prescription opioid misuse in patients with chronic pain: The mediating role of opioid craving","volume":"15","author":"Martel","year":"2014","journal-title":"The Journal of Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0685","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/ALN.0b013e318209aba7","article-title":"Involvement of the lateral amygdala in the antiallodynic and reinforcing effects of heroin in rats after peripheral nerve injury","volume":"114","author":"Martin","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0690","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1037\/a0013597","article-title":"Chronic pain alters drug self-administration: Implications for addiction and pain mechanisms","volume":"16","author":"Martin","year":"2008","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0695","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00000542-200702000-00020","article-title":"Opioid self-administration in the nerve-injured rat relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics","volume":"106","author":"Martin","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0700","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.neuron.2019.02.029","article-title":"Pain-induced negative affect is mediated via recruitment of the nucleus accumbens kappa opioid system","volume":"102","author":"Massaly","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/bs.irn.2020.09.002_bb0705","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fnins.2016.00480","article-title":"A trigger for opioid misuse: Chronic pain and stress dysregulate the mesolimbic pathway and kappa opioid system","volume":"10","author":"Massaly","year":"2016","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0710","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.neuron.2014.04.030","article-title":"Separate GABA afferents to dopamine neurons mediate acute action of opioids, development of tolerance, and expression of withdrawal","volume":"82","author":"Matsui","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/bs.irn.2020.09.002_bb0715","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18247","article-title":"Locus coeruleus to basolateral amygdala noradrenergic projections promote anxiety-like behavior","volume":"6","author":"McCall","year":"2017","journal-title":"eLife"},{"key":"10.1016\/bs.irn.2020.09.002_bb0720","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1037\/pha0000042","article-title":"Effects of repeated morphine on intracranial self-stimulation in male rats in the absence or presence of a noxious pain stimulus","volume":"23","author":"Miller","year":"2015","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0725","doi-asserted-by":"crossref","first-page":"107689","DOI":"10.1016\/j.neuropharm.2019.107689","article-title":"Interactions between pain states and opioid reward assessed with intracranial self-stimulation in rats","volume":"160","author":"Moerke","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0730","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011603","article-title":"Amitriptyline for neuropathic pain in adults","volume":"7","author":"Moore","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/bs.irn.2020.09.002_bb0735","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrn.2016.165","article-title":"Ventral tegmental area: Cellular heterogeneity, connectivity and behaviour","volume":"18","author":"Morales","year":"2017","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0740","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/npp.2009.199","article-title":"Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: Conditioned place preference to morphine induces CREB phosphorylation","volume":"35","author":"Mor\u00f3n","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0745","doi-asserted-by":"crossref","first-page":"a012005","DOI":"10.1101\/cshperspect.a012005","article-title":"Roles of nucleus accumbens CREB and dynorphin in dysregulation of motivation","volume":"3","author":"Muschamp","year":"2013","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"10.1016\/bs.irn.2020.09.002_bb0750","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1460-9568.2006.04569.x","article-title":"Neuropathic pain is enhanced in delta-opioid receptor knockout mice","volume":"23","author":"Nadal","year":"2006","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0755","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jpain.2015.05.002","article-title":"Estimates of pain prevalence and severity in adults: United States, 2012","volume":"16","author":"Nahin","year":"2015","journal-title":"The Journal of Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0760","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nature14366","article-title":"A circuit mechanism for differentiating positive and negative associations","volume":"520","author":"Namburi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/bs.irn.2020.09.002_bb0765","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/sj.npp.1300858","article-title":"Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala","volume":"31","author":"Narita","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0770","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/sj.npp.1300527","article-title":"Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state","volume":"30","author":"Narita","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0775","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/j.pain.0000000000001167","article-title":"Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain","volume":"159","author":"Nation","year":"2018","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0780","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/j.pain.0000000000001458","article-title":"Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain","volume":"160","author":"Navratilova","year":"2019","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0785","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/nn.3811","article-title":"Reward and motivation in pain and pain relief","volume":"17","author":"Navratilova","year":"2014","journal-title":"Nature Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0790","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1523\/JNEUROSCI.3862-14.2015","article-title":"Endogenous opioid activity in the anterior cingulate cortex is required for relief of pain","volume":"35","author":"Navratilova","year":"2015","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0795","doi-asserted-by":"crossref","first-page":"20709","DOI":"10.1073\/pnas.1214605109","article-title":"Pain relief produces negative reinforcement through activation of mesolimbic reward-valuation circuitry","volume":"109","author":"Navratilova","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.irn.2020.09.002_bb0800","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0022-3565(24)37596-2","article-title":"Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys","volume":"286","author":"Negus","year":"1998","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2020.09.002_bb0805","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.peptides.2018.10.007","article-title":"Determinants of opioid abuse potential: Insights using intracranial self-stimulation","volume":"112","author":"Negus","year":"2019","journal-title":"Peptides"},{"key":"10.1016\/bs.irn.2020.09.002_bb0810","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.biopsych.2005.09.018","article-title":"The mesolimbic dopamine reward circuit in depression","volume":"59","author":"Nestler","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1016\/bs.irn.2020.09.002_bb0815","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.tips.2010.04.003","article-title":"Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopaminergic transmission","volume":"31","author":"Niikura","year":"2010","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/bs.irn.2020.09.002_bb0820","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neulet.2008.02.059","article-title":"Direct evidence for the involvement of endogenous \u03b2-endorphin in the suppression of the morphine-induced rewarding effect under a neuropathic pain-like state","volume":"435","author":"Niikura","year":"2008","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.irn.2020.09.002_bb0825","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pain.2008.12.006","article-title":"Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain","volume":"141","author":"Obara","year":"2009","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0830","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0306-4522(02)00699-1","article-title":"Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: Involvement of G-protein-coupled receptor kinase 2","volume":"116","author":"Ozaki","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0835","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1046\/j.1471-4159.2002.01071.x","article-title":"Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: Implication of the reduction in \u03bc-opioid receptor functions in the ventral tegmental area","volume":"82","author":"Ozaki","year":"2002","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.irn.2020.09.002_bb0840","first-page":"735","article-title":"Behavioral pharmacology of novel kappa opioid receptor antagonists in rats","volume":"22","author":"Page","year":"2019","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0845","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.conb.2012.02.014","article-title":"Amygdala microcircuits mediating fear expression and extinction","volume":"22","author":"Pare","year":"2012","journal-title":"Current Opinion in Neurobiology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0850","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jpainsymman.2010.03.012","article-title":"Aberrant drug-related behavior observed during clinical studies involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet for breakthrough pain","volume":"41","author":"Passik","year":"2011","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/bs.irn.2020.09.002_bb0855","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1097\/j.pain.0000000000001553","article-title":"Kappa opioid signaling in the right central amygdala causes hind paw specific loss of diffuse noxious inhibitory controls in experimental neuropathic pain","volume":"160","author":"Phelps","year":"2019","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0860","first-page":"93","article-title":"Pain management with intrathecal clonidine in a colon cancer patient with opioid hyperalgesia: Case presentation","volume":"26","author":"Pirbudak","year":"2014","journal-title":"A\u01e7r\u0131"},{"key":"10.1016\/bs.irn.2020.09.002_bb0865","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev-pharmtox-010715-103042","article-title":"Emerging role of spinal dynorphin in chronic pain, a therapeutic perspective","volume":"56","author":"Podvin","year":"2016","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0870","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/j.pain.0000000000000798","article-title":"Reward, motivation and emotion of pain and its relief","volume":"158","author":"Porreca","year":"2017","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0875","article-title":"In vivo delta opioid receptor internalization controls behavioral effects of agonists","volume":"4,5","author":"Pradhan","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2020.09.002_bb0880","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.tips.2011.06.008","article-title":"The delta opioid receptor: An evolving target for the treatment of brain disorders","volume":"32","author":"Pradhan","year":"2011","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/bs.irn.2020.09.002_bb0885","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1111\/bph.12591","article-title":"\u03b4-Opioid receptor agonists inhibit migraine-related hyperalgesia, aversive state and cortical spreading depression in mice","volume":"171","author":"Pradhan","year":"2014","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0890","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41583-018-0012-5","article-title":"Transition to chronic pain: Opportunities for novel therapeutics","volume":"19","author":"Price","year":"2018","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0895","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0304-3959(85)90026-0","article-title":"A psychophysical analysis of morphine analgesia","volume":"22","author":"Price","year":"1985","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0900","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine side effects in beta-arrestin 2 knockout mice","volume":"314","author":"Raehal","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2020.09.002_bb0905","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1126\/science.277.5328.968","article-title":"Pain affect encoded in human anterior cingulate but not somatosensory cortex","volume":"277","author":"Rainville","year":"1997","journal-title":"Science"},{"key":"10.1016\/bs.irn.2020.09.002_bb0910","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1097\/j.pain.0000000000001328","article-title":"Analgesic effects of a novel pH-dependent \u03bc-opioid receptor agonist in models of neuropathic and abdominal pain","volume":"159","author":"Rodriguez-Gaztelumendi","year":"2018","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0915","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1021\/acsmedchemlett.9b00335","article-title":"\u03b2-Fluorofentanyls are pH-sensitive Mu opioid receptor agonists","volume":"10","author":"Rosas","year":"2019","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"10.1016\/bs.irn.2020.09.002_bb0920","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1523\/JNEUROSCI.17-17-06565.1997","article-title":"Kappa-opioid receptor activation modulates Ca2+ currents and secretion in isolated neuroendocrine nerve terminals","volume":"17","author":"Rusin","year":"1997","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0925","first-page":"161","article-title":"Dynorphin a peptides","volume":"13","author":"Sch\u00e4fer","year":"2000","journal-title":"Molecular Diagnosis & Therapy"},{"key":"10.1016\/bs.irn.2020.09.002_bb0930","doi-asserted-by":"crossref","first-page":"19384","DOI":"10.1523\/JNEUROSCI.1979-13.2013","article-title":"Long-term antagonism of \u03ba opioid receptors prevents escalation of and increased motivation for heroin intake","volume":"33","author":"Schlosburg","year":"2013","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0935","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.cell.2017.10.035","article-title":"Bias factor and therapeutic window correlate to predict safer opioid analgesics","volume":"171","author":"Schmid","year":"2017","journal-title":"Cell"},{"key":"10.1016\/bs.irn.2020.09.002_bb0940","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0304-3959(88)90225-4","article-title":"Motivational effects of opioids in an animal model of prolonged inflammatory pain: Alteration in the effects of kappa- but not of mu-receptor agonists","volume":"35","author":"Shippenberg","year":"1988","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0945","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pharmthera.2007.06.011","article-title":"Dynorphin and the pathophysiology of drug addiction","volume":"116","author":"Shippenberg","year":"2007","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.irn.2020.09.002_bb9090","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.neuron.2015.03.066","article-title":"Spatiotemporal control of opioid signaling and behavior","volume":"86","author":"Siuda","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/bs.irn.2020.09.002_bb0950","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.coph.2016.11.007","article-title":"Biased mu-opioid receptor ligands: A promising new generation of pain therapeutics","volume":"32","author":"Siuda","year":"2017","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb0955","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.joca.2016.01.135","article-title":"Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: Systematic analytic review","volume":"24","author":"Smith","year":"2016","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1016\/bs.irn.2020.09.002_bb0960","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.neuron.2018.08.044","article-title":"Kappa opioid receptor distribution and function in primary afferents","volume":"99","author":"Snyder","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/bs.irn.2020.09.002_bb0965","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.aai8636","article-title":"A nontoxic pain killer designed by modeling of pathological receptor conformations","volume":"355","author":"Spahn","year":"2017","journal-title":"Science"},{"key":"10.1016\/bs.irn.2020.09.002_bb0970","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0022-3565(25)24151-9","article-title":"Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors","volume":"248","author":"Stein","year":"1989","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2020.09.002_bb9095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature10194","article-title":"Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking","volume":"475","author":"Stuber","year":"2011","journal-title":"Nature"},{"key":"10.1016\/bs.irn.2020.09.002_bb0975","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0304-3959(94)90130-9","article-title":"Conditioned place preference paradigm: A novel approach for analgesic drug assessment against chronic pain","volume":"58","author":"Sufka","year":"1994","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0980","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/j.pain.0000000000000494","article-title":"Mesolimbic dopamine signaling in acute and chronic pain: Implications for motivation, analgesia, and addiction","volume":"157","author":"Taylor","year":"2016","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb0985","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1523\/JNEUROSCI.4036-14.2015","article-title":"Microglia disrupt mesolimbic reward circuitry in chronic pain","volume":"35","author":"Taylor","year":"2015","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb0990","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neuron.2016.12.005","article-title":"Pathway- and cell-specific kappa-opioid receptor modulation of excitation-inhibition balance differentially gates D1 and D2 accumbens neuron activity","volume":"93","author":"Tejeda","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/bs.irn.2020.09.002_bb0995","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/ALN.0000000000000993","article-title":"Activation of peripheral \u03bc-opioid receptors by dermorphin [D-Arg2, Lys4] (1-4) amide leads to modality-preferred inhibition of neuropathic pain","volume":"124","author":"Tiwari","year":"2016","journal-title":"Anesthesiology"},{"key":"10.1016\/bs.irn.2020.09.002_bb1000","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/nm.2229","article-title":"Getting the pain you expect: Mechanisms of placebo, nocebo and reappraisal effects in humans","volume":"16","author":"Tracey","year":"2010","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.irn.2020.09.002_bb1005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.neuron.2007.07.012","article-title":"The cerebral signature for pain perception and its modulation","volume":"55","author":"Tracey","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/bs.irn.2020.09.002_bb1010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.brainresprot.2005.03.003","article-title":"Real time computation of in vivo drug levels during drug self-administration experiments","volume":"15","author":"Tsibulsky","year":"2005","journal-title":"Brain Research. Brain Research Protocols"},{"key":"10.1016\/bs.irn.2020.09.002_bb1015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5055\/jom.2011.0049","article-title":"Peripheral opioid receptor agonists for analgesia: A comprehensive review","volume":"7","author":"Vadivelu","year":"2011","journal-title":"Journal of Opioid Management"},{"issue":"Suppl. 10","key":"10.1016\/bs.irn.2020.09.002_bb1020","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/AJP.0b013e3181c49e3a","article-title":"Delta and kappa opioid receptors as suitable drug targets for pain","volume":"26","author":"Vanderah","year":"2010","journal-title":"The Clinical Journal of Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb1025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejphar.2008.01.011","article-title":"Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors","volume":"583","author":"Vanderah","year":"2008","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb1030","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1124\/jpet.104.065391","article-title":"FE200041 (D-Phe-D-Phe-D-Nle-D-Arg-NH2): A peripheral efficacious kappa opioid agonist with unprecedented selectivity","volume":"310","author":"Vanderah","year":"2004","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2020.09.002_bb1035","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00213-013-3195-5","article-title":"Role of kappa-opioid receptors in stress and anxiety-related behavior","volume":"229","author":"Van't Veer","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb1040","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1021\/acs.jmedchem.6b00748","article-title":"Mitragynine\/corynantheidine pseudoindoxyls as opioid analgesics with Mu agonism and delta antagonism, which do not recruit \u03b2-arrestin-2","volume":"59","author":"V\u00e1radi","year":"2016","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.irn.2020.09.002_bb1045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2049-9256-1-9","article-title":"The amygdala between sensation and affect: A role in pain","volume":"1","author":"Veinante","year":"2013","journal-title":"Journal of Molecular Psychiatry"},{"key":"10.1016\/bs.irn.2020.09.002_bb9100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/arclin\/acp014","article-title":"Executive function and decision-making in women with fibromyalgia","volume":"24","author":"Verdejo-Garc\u00eda","year":"2009","journal-title":"Archives of Clinical Neuropsychology"},{"key":"10.1016\/bs.irn.2020.09.002_bb1050","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1111\/bph.14353","article-title":"Tolerance to high-internalizing \u03b4 opioid receptor agonist is critically mediated by arrestin 2","volume":"175","author":"Vicente-Sanchez","year":"2018","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb1055","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrn1704","article-title":"Pain and emotion interactions in subregions of the cingulate gyrus","volume":"6","author":"Vogt","year":"2005","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb1060","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in chronic pain\u2014Misconceptions and mitigation strategies","volume":"374","author":"Volkow","year":"2016","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.irn.2020.09.002_bb1065","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cell.2015.07.046","article-title":"The brain on drugs: From reward to addiction","volume":"162","author":"Volkow","year":"2015","journal-title":"Cell"},{"key":"10.1016\/bs.irn.2020.09.002_bb1070","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/386830a0","article-title":"Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects","volume":"386","author":"Volkow","year":"1997","journal-title":"Nature"},{"key":"10.1016\/bs.irn.2020.09.002_bb1075","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/0003-4819-155-5-201109060-00011","article-title":"Long-term opioid therapy reconsidered","volume":"155","author":"Von Korff","year":"2011","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/bs.irn.2020.09.002_bb1080","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","article-title":"Rates of opioid misuse, abuse, and addiction in chronic pain: A systematic review and data synthesis","volume":"156","author":"Vowles","year":"2015","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.09.002_bb1085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/7854_2014_344","article-title":"The self-administration of analgesic drugs in experimentally induced chronic pain","volume":"20","author":"Wade","year":"2014","journal-title":"Current Topics in Behavioral Neurosciences"},{"key":"10.1016\/bs.irn.2020.09.002_bb1090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079239","article-title":"Effect of chronic pain on fentanyl self-administration in mice","volume":"8","author":"Wade","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2020.09.002_bb9105","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jpsychores.2010.07.013","article-title":"Altered associative learning and emotional decision making in fibromyalgia","volume":"70","author":"Walteros","year":"2011","journal-title":"The Journal of Psychosomatic Research"},{"key":"10.1016\/bs.irn.2020.09.002_bb1095","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/pme.12800","article-title":"Efficacy and safety of duloxetine on osteoarthritis knee pain: A meta-analysis of randomized controlled trials","volume":"16","author":"Wang","year":"2015","journal-title":"Pain Medicine"},{"key":"10.1016\/bs.irn.2020.09.002_bb1100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1124\/mol.113.089649","article-title":"Identification of novel functionally selective \u03ba-opioid receptor scaffolds","volume":"85","author":"White","year":"2014","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb1105","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: A systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/bs.irn.2020.09.002_bb1110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1124\/jpet.115.228940","article-title":"Effects of acute and repeated administration of oxycodone and naloxone-precipitated withdrawal on intracranial self-stimulation in rats","volume":"356","author":"Wiebelhaus","year":"2016","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2020.09.002_bb1115","article-title":"Gabapentin for chronic neuropathic pain in adults","volume":"6","author":"Wiffen","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/bs.irn.2020.09.002_bb1120","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1152\/physrev.2001.81.1.299","article-title":"Cellular and synaptic adaptations mediating opioid dependence","volume":"81","author":"Williams","year":"2001","journal-title":"Physiological Reviews"},{"key":"10.1016\/bs.irn.2020.09.002_bb1125","doi-asserted-by":"crossref","first-page":"14611","DOI":"10.1038\/ncomms14611","article-title":"Endogenous opioids regulate moment-to-moment neuronal communication and excitability","volume":"8","author":"Winters","year":"2017","journal-title":"Nature Communications"},{"key":"10.1016\/bs.irn.2020.09.002_bb1130","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1098\/rstb.2006.1854","article-title":"Role of brain dopamine in food reward and reinforcement","volume":"361","author":"Wise","year":"2006","journal-title":"Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences"},{"key":"10.1016\/bs.irn.2020.09.002_bb1135","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/npp.2013.261","article-title":"The development and maintenance of drug addiction","volume":"39","author":"Wise","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb9110","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neuroscience.2008.01.040","article-title":"Ethanol dually modulates GABAergic synaptic transmission onto dopaminergic neurons in ventral tegmental area: Role of mu-opioid receptors","volume":"153","author":"Xiao","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb1140","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1523\/JNEUROSCI.5552-03.2004","article-title":"Neuropathic pain activates the endogenous \u03ba opioid system in mouse spinal cord and induces opioid receptor tolerance","volume":"24","author":"Xu","year":"2004","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb1145","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/ACO.0000000000000116","article-title":"The anxiodepressive comorbidity in chronic pain","volume":"27","author":"Yalcin","year":"2014","journal-title":"Current Opinion in Anaesthesiology"},{"key":"10.1016\/bs.irn.2020.09.002_bb1150","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1213\/ane.0b013e3181732776","article-title":"Postoperative ketamine administration decreases morphine consumption in major abdominal surgery: A prospective, randomized, double-blind, controlled study","volume":"106","author":"Zakine","year":"2008","journal-title":"Anesthesia and Analgesia"},{"key":"10.1016\/bs.irn.2020.09.002_bb1155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12264-012-1206-x","article-title":"Interaction and regulatory functions of \u03bc- and \u03b4-opioid receptors in nociceptive afferent neurons","volume":"28","author":"Zhang","year":"2012","journal-title":"Neuroscience Bulletin"},{"key":"10.1016\/bs.irn.2020.09.002_bb1160","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1038\/npp.2014.77","article-title":"Persistent pain facilitates response to morphine reward by downregulation of central amygdala GABAergic function","volume":"39","author":"Zhang","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2020.09.002_bb1165","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1523\/JNEUROSCI.18-07-02538.1998","article-title":"Developmental expression of the \u03bc, \u03ba, and \u03b4 opioid receptor mRNAs in mouse","volume":"18","author":"Zhu","year":"1998","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.09.002_bb1170","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0896-6273(00)80836-3","article-title":"Retention of supraspinal delta-like analgesia and loss of morphine tolerance in \u03b4 opioid receptor knockout mice","volume":"24","author":"Zhu","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/bs.irn.2020.09.002_bb1175","doi-asserted-by":"crossref","first-page":"7754","DOI":"10.1523\/JNEUROSCI.0439-05.2005","article-title":"Placebo effects mediated by endogenous opioid activity on \u03bc-opioid receptors","volume":"25","author":"Zubieta","year":"2005","journal-title":"The Journal of Neuroscience"}],"container-title":["International Review of Neurobiology","Neurobiology of Addiction and Co-Morbid Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774220301409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774220301409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T21:14:33Z","timestamp":1758748473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774220301409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780128203552"],"references-count":255,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2020.09.002","relation":{},"ISSN":["0074-7742"],"issn-type":[{"type":"print","value":"0074-7742"}],"subject":[],"published":{"date-parts":[[2021]]}}}